79 related articles for article (PubMed ID: 7808003)
1. Lymphoid and non-lymphoid tumors in E kappa-myc transgenic rabbits.
Sethupathi P; Spieker-Polet H; Polet H; Yam PC; Tunyaplin C; Knight KL
Leukemia; 1994 Dec; 8(12):2144-55. PubMed ID: 7808003
[TBL] [Abstract][Full Text] [Related]
2. E mu N- and E mu L-myc cooperate with E mu pim-1 to generate lymphoid tumors at high frequency in double-transgenic mice.
Möröy T; Verbeek S; Ma A; Achacoso P; Berns A; Alt F
Oncogene; 1991 Nov; 6(11):1941-8. PubMed ID: 1658705
[TBL] [Abstract][Full Text] [Related]
3. H-2/myc, E mu/myc, and c-myc transgenic mice: potent sources of early hematopoietic cell lines.
Roland J; Morello D
Cell Growth Differ; 1993 Nov; 4(11):891-900. PubMed ID: 8297795
[TBL] [Abstract][Full Text] [Related]
4. B-cell tumorigenesis in mice carrying a yeast artificial chromosome-based immunoglobulin heavy/c-myc translocus is independent of the heavy chain intron enhancer (Emu).
Palomo C; Zou X; Nicholson IC; Bützler C; Brüggemann M
Cancer Res; 1999 Nov; 59(21):5625-8. PubMed ID: 10554044
[TBL] [Abstract][Full Text] [Related]
5. Detection of immunoglobulin kappa light-chain gene rearrangement patterns by Southern blot analysis.
Beishuizen A; Verhoeven MA; Mol EJ; van Dongen JJ
Leukemia; 1994 Dec; 8(12):2228-36; discussion 2237-9. PubMed ID: 7808012
[TBL] [Abstract][Full Text] [Related]
6. Transgenic rabbits with lymphocytic leukemia induced by the c-myc oncogene fused with the immunoglobulin heavy chain enhancer.
Knight KL; Spieker-Polet H; Kazdin DS; Oi VT
Proc Natl Acad Sci U S A; 1988 May; 85(9):3130-4. PubMed ID: 2834733
[TBL] [Abstract][Full Text] [Related]
7. Transgenic N-myc mouse model for indolent B cell lymphoma: tumor characterization and analysis of genetic alterations in spontaneous and retrovirally accelerated tumors.
Sheppard RD; Samant SA; Rosenberg M; Silver LM; Cole MD
Oncogene; 1998 Oct; 17(16):2073-85. PubMed ID: 9798678
[TBL] [Abstract][Full Text] [Related]
8. Survival and death of prelymphomatous B-cells from N-myc/bcl-2 double transgenic mice correlates with the regulation of intracellular Ca2+ fluxes.
Zörnig M; Busch G; Beneke R; Gulbins E; Lang F; Ma A; Korsmeyer S; Möröy T
Oncogene; 1995 Nov; 11(10):2165-74. PubMed ID: 7478538
[TBL] [Abstract][Full Text] [Related]
9. Molecular Ig gene analysis reveals that monocytoid B cell lymphoma is a malignancy of mature B cells carrying somatically mutated V region genes and suggests that rearrangement of the kappa-deleting element (resulting in deletion of the Ig kappa enhancers) abolishes somatic hypermutation in the human.
Küppers R; Hajadi M; Plank L; Rajewsky K; Hansmann ML
Eur J Immunol; 1996 Aug; 26(8):1794-800. PubMed ID: 8765023
[TBL] [Abstract][Full Text] [Related]
10. Cell populations during tumorigenesis in Eu-myc transgenic mice.
Sidman CL; Shaffer DJ; Jacobsen K; Vargas SR; Osmond DG
Leukemia; 1993 Jun; 7(6):887-95. PubMed ID: 8501983
[TBL] [Abstract][Full Text] [Related]
11. Influence of a V kappa 8 L chain transgene on endogenous rearrangements and the immune response to the HA(Sb) determinant on influenza virus.
Carmack CE; Camper SA; Mackle JJ; Gerhard WU; Weigert MG
J Immunol; 1991 Sep; 147(6):2024-33. PubMed ID: 1909739
[TBL] [Abstract][Full Text] [Related]
12. Simultaneously arising Ly-1(CD5) B cell lymphomas have identical expressed IgH and kappa-genes but different nonproductive heavy chain rearrangements.
Van Houten N; Haughton G
J Immunol; 1990 Jan; 144(2):745-51. PubMed ID: 1688585
[TBL] [Abstract][Full Text] [Related]
13. The transgenic window on lymphoid malignancy.
Adams JM; Harris AW; Vaux DL; Alexander WS; Rosenbaum H; Klinken SP; Strasser A; Bath ML; McNeall J; Cory S
Princess Takamatsu Symp; 1989; 20():297-309. PubMed ID: 2518688
[TBL] [Abstract][Full Text] [Related]
14. Retroviral infection accelerates T lymphomagenesis in E mu-N-ras transgenic mice by activating c-myc or N-myc.
Haupt Y; Harris AW; Adams JM
Oncogene; 1992 May; 7(5):981-6. PubMed ID: 1570158
[TBL] [Abstract][Full Text] [Related]
15. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
Yu D; Thomas-Tikhonenko A
Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625
[TBL] [Abstract][Full Text] [Related]
16. Loss of Fas/Apo-1 receptor accelerates lymphomagenesis in E mu L-MYC transgenic mice but not in animals infected with MoMuLV.
Zörnig M; Grzeschiczek A; Kowalski MB; Hartmann KU; Möröy T
Oncogene; 1995 Jun; 10(12):2397-401. PubMed ID: 7784089
[TBL] [Abstract][Full Text] [Related]
17. Rearrangement of the 5' cluster region of the BCL2 gene in lymphoid neoplasm: a summary of nine cases.
Yabumoto K; Akasaka T; Muramatsu M; Kadowaki N; Hayashi T; Ohno H; Fukuhara S; Okuma M
Leukemia; 1996 Jun; 10(6):970-7. PubMed ID: 8667654
[TBL] [Abstract][Full Text] [Related]
18. Rapid induction of B-cell lymphomas in mice carrying a human IgH/c-mycYAC.
Bützler C; Zou X; Popov AV; Brüggemann M
Oncogene; 1997 Mar; 14(11):1383-8. PubMed ID: 9178899
[TBL] [Abstract][Full Text] [Related]
19. The role of immunoglobulin kappa elements in c-myc activation.
Hörtnagel K; Mautner J; Strobl LJ; Wolf DA; Christoph B; Geltinger C; Polack A
Oncogene; 1995 Apr; 10(7):1393-401. PubMed ID: 7731690
[TBL] [Abstract][Full Text] [Related]
20. Detection of immunoglobulin gene rearrangement of B cell non-Hodgkin's lymphomas and leukemias in fresh, unfixed and formalin-fixed, paraffin-embedded tissue by polymerase chain reaction.
Inghirami G; Szabolcs MJ; Yee HT; Corradini P; Cesarman E; Knowles DM
Lab Invest; 1993 Jun; 68(6):746-57. PubMed ID: 8515660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
